Mumbai, November 26, 2015 : ASPA announced its support for Pharmasafe India, a two-day comprehensive Conference on Anti-Counterfeiting and Brand Protection started today and will continue till tomorrow (24, 25 November, 2015) at Courtyard Marriott, Mumbai. The conference will bring together industry delegates and speakers representing cross-section of stake-holders: top business leaders from Pharmaceutical manufacturing companies, Pharmacists, Anti-counterfeiting solutions and services providers, Government and regulatory authorities etc., at a common platform to enable panel discussions, presentations, sharing of insights, best practices and strategies to tackle the Counterfeiting challenge in India.
On the occasion Mr. U K Gupta, President, ASPA said, “We are proud to support this effort to combat Counterfeit and thanks the organisers of the event to bring together all industry stakeholders fields under one roof after understanding the emerging situation in Pharma Industry in India and across the globe. Made in India pharmaceutical product have great opportunity in India and overseas market because of their quality.
However, with the increase of counterfeiting in pharmaceutical sector, there is a constant need to ensure that “Made in India” pharmaceutical product are of highest quality, genuine and secured till its deliver to the end consumer. Usage of authentication solutions in product packaging ensure that a consumer get the genuine product. Further with the help of IT and mobile based solutions, brand owners, govt. authorities and consumer can easily identified them via website, mobile app or SMS verification. We look forward for positive responses from Government and Industries to make safe and secure Pharma in India, he further stated.
Addressing the conference Mr. Nityanand Shenoy, Governing Body Member of ASPA highlighted the views on, “How to select authentication solutions according to Brand owner’s needs. Fighting counterfeiting need a strategy which should include, analysis of problem, the organisation commitment towards fighting counterfeiting, the right selection of authentication solutions and its proper implementation”.
The conference programme will feature presentations, case studies and panel discussions addressing topics such as: Indian Pharma- Counterfeit Market overview, Coordinated efforts against counterfeiting – role of industry association, retailers and pharmacists; Overview of authentication solutions and technologies, effect of parallel trade on the industry and ways to tackle it; Government initiatives, regulations, policies and strategies against drug counterfeiting; usage of mobile product authentication for protection against counterfeiting; packaging innovations and latest development in track & trace technologies.
The conference is attended by top industry veterans and anti-counterfeiting experts such as Sudhansh Pant, Joint Sectreary (Policy), Department of Pharmaceuticals, Government of India, Dr. K Bangarurajan, Deputy Drug Controller of India (West Zone), Arvind Kukrety, Deputy Drug Controller of India (Ahemdabad), Omprakash Sadhwani, Joint Commissioner, Food and Drug Administration (Maharashtra), Ajit Singh, Chairman, ACG Worldwide, Dominique Woloch, Regional Security Director – Turkey, Middle East and South Asia, Sanofi, Dr Shailesh Ayyangar, Vice President – South Asia, Sanofi & President, Organisation of Pharmaceutical Producers of India, Dr. Nirod Kumar Singh, Associate Director, Healthcare Practice, Frost & Sullivan and Sharad Tyagi, Managing Director, Boehringer Ingelheim India, , Dr VSV Vadlamudi Rao, President, Indian Pharmaceutical Association, Nityanand Shenoy, President & Managing Director, PRS Permacel, Dr Vaibhav Kulkarni, Director – Regulatory, Abbott Nutrition International and Appadurai A, Country Manager, HP Indigo and Inkjet Solutions and many more.
Corporate Comm India(CCI Newswire)
